Elekta

The investor meeting will be held on Saturday, May 4, at 9:00 – 11:00 a.m. local time (BST), at the Crowne Plaza Glasgow hotel, situated close to the Scottish Exhibition and Conference Centre. Speakers will include Gustaf Salford, President and CEO, Maurits Wolleswinkel, Head of Linac and Software Solutions, as well as other leaders of Elekta. To attend, please register via Elekta Investor Meeting at ESTRO 2024 - Elekta by April 26.

Welcome!

# # #

For further information, please contact:
Peter Nyquist, Head of Investor Relations
Tel: +46 70 575 29 06, e-mail: peter.nyquist@elekta.com
Time zone: CET (Central European Time)

Martin Svensson, Investor Relations Manager
Tel. +46 70 221 84 13, e-mail: martin.svensson2@elekta.com
Time zone: CET (Central European Time)

About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,500 employees combine passion, science, and imagination to profoundly change cancer care. We don’t just build technology, we build hope. Elekta is headquartered in Stockholm, Sweden, with offices in more than 40 countries and listed on Nasdaq Stockholm. For more information, visit elekta.com or follow @Elekta on “X”, formerly known as Twitter.